Publication Date:
2019-06-21
Description:
The role of glucosylsphingosine (lyso-Gb1), a downstream metabolic product of glucosylceramide, for monitoring treated and untreated children with Gaucher disease (GD) has not yet been studied. We reviewed the clinical charts of 81 children (
Print ISSN:
1661-6596
Electronic ISSN:
1422-0067
Topics:
Chemistry and Pharmacology